

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.27682559 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.25713883 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.89155712 |
| 4 | neural tube formation (GO:0001841) | 4.47782296 |
| 5 | presynaptic membrane assembly (GO:0097105) | 4.26692039 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 4.26153915 |
| 7 | central nervous system myelination (GO:0022010) | 4.26153915 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.19457667 |
| 9 | nucleobase catabolic process (GO:0046113) | 4.14617038 |
| 10 | presynaptic membrane organization (GO:0097090) | 4.03081296 |
| 11 | vocalization behavior (GO:0071625) | 3.79671456 |
| 12 | glutamate secretion (GO:0014047) | 3.78106236 |
| 13 | regulation of cilium movement (GO:0003352) | 3.75916606 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 3.75591501 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69173190 |
| 16 | postsynaptic membrane organization (GO:0001941) | 3.69137486 |
| 17 | sulfation (GO:0051923) | 3.68937389 |
| 18 | protein localization to synapse (GO:0035418) | 3.67938342 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.65002741 |
| 20 | neuron recognition (GO:0008038) | 3.58128732 |
| 21 | neuronal action potential propagation (GO:0019227) | 3.56995513 |
| 22 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.54605217 |
| 23 | dopamine transport (GO:0015872) | 3.51611491 |
| 24 | activated T cell proliferation (GO:0050798) | 3.50479136 |
| 25 | axonal fasciculation (GO:0007413) | 3.50104556 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.46653666 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.44595434 |
| 28 | L-fucose catabolic process (GO:0042355) | 3.43826939 |
| 29 | fucose catabolic process (GO:0019317) | 3.43826939 |
| 30 | L-fucose metabolic process (GO:0042354) | 3.43826939 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.39639300 |
| 32 | protein K11-linked deubiquitination (GO:0035871) | 3.39252454 |
| 33 | protein localization to cilium (GO:0061512) | 3.35434604 |
| 34 | positive regulation of synapse assembly (GO:0051965) | 3.34238273 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.30135096 |
| 36 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.29237819 |
| 37 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.23884103 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.23122223 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.17412375 |
| 40 | negative regulation of mast cell activation (GO:0033004) | 3.15702265 |
| 41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.15554766 |
| 42 | establishment of protein localization to Golgi (GO:0072600) | 3.15285531 |
| 43 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14648741 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.14527254 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.14431866 |
| 46 | membrane assembly (GO:0071709) | 3.14386804 |
| 47 | startle response (GO:0001964) | 3.14184415 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 3.13370088 |
| 49 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12558651 |
| 50 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.12161981 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.12153329 |
| 52 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.12071404 |
| 53 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.12071404 |
| 54 | cAMP catabolic process (GO:0006198) | 3.11775437 |
| 55 | cell migration in hindbrain (GO:0021535) | 3.10288600 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 3.09975781 |
| 57 | dendrite development (GO:0016358) | 3.09159096 |
| 58 | somite development (GO:0061053) | 3.08115885 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.07552233 |
| 60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.06591057 |
| 61 | regulation of synaptic vesicle transport (GO:1902803) | 3.03840663 |
| 62 | locomotory exploration behavior (GO:0035641) | 3.03041389 |
| 63 | transmission of nerve impulse (GO:0019226) | 3.02138583 |
| 64 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00261079 |
| 65 | tryptophan catabolic process (GO:0006569) | 2.98666733 |
| 66 | indole-containing compound catabolic process (GO:0042436) | 2.98666733 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 2.98666733 |
| 68 | epithelial cilium movement (GO:0003351) | 2.98324086 |
| 69 | kynurenine metabolic process (GO:0070189) | 2.95598500 |
| 70 | protein polyglutamylation (GO:0018095) | 2.95023557 |
| 71 | protein neddylation (GO:0045116) | 2.94542484 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.94432513 |
| 73 | mechanosensory behavior (GO:0007638) | 2.90758131 |
| 74 | retinal ganglion cell axon guidance (GO:0031290) | 2.86871045 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 2.86034637 |
| 76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.85762511 |
| 77 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.85407044 |
| 78 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.84287000 |
| 79 | detection of light stimulus involved in visual perception (GO:0050908) | 2.84287000 |
| 80 | neurotransmitter uptake (GO:0001504) | 2.83918286 |
| 81 | long-term synaptic potentiation (GO:0060291) | 2.82555335 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 2.82437379 |
| 83 | cyclic nucleotide catabolic process (GO:0009214) | 2.81931180 |
| 84 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.81872713 |
| 85 | negative regulation of telomere maintenance (GO:0032205) | 2.80935835 |
| 86 | platelet dense granule organization (GO:0060155) | 2.80624182 |
| 87 | regulation of synapse assembly (GO:0051963) | 2.79638573 |
| 88 | regulation of collateral sprouting (GO:0048670) | 2.79582866 |
| 89 | regulation of telomere maintenance (GO:0032204) | 2.77652541 |
| 90 | nonmotile primary cilium assembly (GO:0035058) | 2.77181637 |
| 91 | tryptophan metabolic process (GO:0006568) | 2.77054008 |
| 92 | reflex (GO:0060004) | 2.75589290 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74638246 |
| 94 | negative regulation of axon extension (GO:0030517) | 2.74434700 |
| 95 | exploration behavior (GO:0035640) | 2.74278633 |
| 96 | protein targeting to Golgi (GO:0000042) | 2.73756866 |
| 97 | auditory behavior (GO:0031223) | 2.73661082 |
| 98 | negative regulation of axonogenesis (GO:0050771) | 2.73508952 |
| 99 | embryonic epithelial tube formation (GO:0001838) | 2.73332083 |
| 100 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.72296185 |
| 101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.72139210 |
| 102 | transferrin transport (GO:0033572) | 2.71961735 |
| 103 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71522366 |
| 104 | fatty acid elongation (GO:0030497) | 2.71439716 |
| 105 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.69640533 |
| 106 | response to pheromone (GO:0019236) | 2.67040092 |
| 107 | neurotransmitter secretion (GO:0007269) | 2.66629889 |
| 108 | adult walking behavior (GO:0007628) | 2.66519279 |
| 109 | regulation of microtubule-based movement (GO:0060632) | 2.66506188 |
| 110 | kidney morphogenesis (GO:0060993) | 2.66361232 |
| 111 | regulation of respiratory system process (GO:0044065) | 2.66034716 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.65843446 |
| 113 | positive regulation of membrane potential (GO:0045838) | 2.64758195 |
| 114 | regulation of synapse structural plasticity (GO:0051823) | 2.64571825 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.64011724 |
| 116 | neuronal action potential (GO:0019228) | 2.63880852 |
| 117 | DNA deamination (GO:0045006) | 2.63832533 |
| 118 | neuronal ion channel clustering (GO:0045161) | 2.63185381 |
| 119 | regulation of neurotransmitter transport (GO:0051588) | 2.63012171 |
| 120 | dopamine biosynthetic process (GO:0042416) | 2.62016120 |
| 121 | synaptic transmission, cholinergic (GO:0007271) | 2.61512981 |
| 122 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.61499930 |
| 123 | cilium organization (GO:0044782) | 2.60946230 |
| 124 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.60806385 |
| 125 | photoreceptor cell development (GO:0042461) | 2.60581735 |
| 126 | synapse assembly (GO:0007416) | 2.60347503 |
| 127 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.60032713 |
| 128 | regulation of dopamine metabolic process (GO:0042053) | 2.59486625 |
| 129 | regulation of catecholamine metabolic process (GO:0042069) | 2.59486625 |
| 130 | regulation of action potential (GO:0098900) | 2.58886613 |
| 131 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.58531543 |
| 132 | response to histamine (GO:0034776) | 2.58080799 |
| 133 | regulation of postsynaptic membrane potential (GO:0060078) | 2.57828614 |
| 134 | negative regulation of dendrite development (GO:2000171) | 2.57763673 |
| 135 | protein K48-linked deubiquitination (GO:0071108) | 2.57132821 |
| 136 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.56827824 |
| 137 | chaperone-mediated protein transport (GO:0072321) | 2.56458462 |
| 138 | myelination (GO:0042552) | 2.56251135 |
| 139 | innervation (GO:0060384) | 2.55951248 |
| 140 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.55805085 |
| 141 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.55805085 |
| 142 | cilium assembly (GO:0042384) | 2.55680588 |
| 143 | proline transport (GO:0015824) | 2.55595762 |
| 144 | serotonin receptor signaling pathway (GO:0007210) | 2.54957172 |
| 145 | establishment of mitochondrion localization (GO:0051654) | 2.54873500 |
| 146 | central nervous system neuron axonogenesis (GO:0021955) | 2.54848947 |
| 147 | cilium morphogenesis (GO:0060271) | 2.54806625 |
| 148 | regulation of glutamate secretion (GO:0014048) | 2.54665863 |
| 149 | peristalsis (GO:0030432) | 2.53986268 |
| 150 | positive regulation of mitochondrial fission (GO:0090141) | 2.53863442 |
| 151 | limb bud formation (GO:0060174) | 2.53671459 |
| 152 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.52923998 |
| 153 | learning (GO:0007612) | 2.52726884 |
| 154 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.52010182 |
| 155 | synaptic vesicle endocytosis (GO:0048488) | 2.51492086 |
| 156 | response to cocaine (GO:0042220) | 2.51348232 |
| 157 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.51055968 |
| 158 | epithelial tube formation (GO:0072175) | 2.49718449 |
| 159 | glycosphingolipid biosynthetic process (GO:0006688) | 2.49222687 |
| 160 | photoreceptor cell maintenance (GO:0045494) | 2.49091374 |
| 161 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48885793 |
| 162 | axoneme assembly (GO:0035082) | 2.48810292 |
| 163 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.48519727 |
| 164 | cornea development in camera-type eye (GO:0061303) | 2.46380396 |
| 165 | otic vesicle formation (GO:0030916) | 2.44449360 |
| 166 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.44321839 |
| 167 | indole-containing compound metabolic process (GO:0042430) | 2.43820290 |
| 168 | cellular ketone body metabolic process (GO:0046950) | 2.43623417 |
| 169 | regulation of neurotransmitter uptake (GO:0051580) | 2.42918309 |
| 170 | olfactory bulb development (GO:0021772) | 2.41729424 |
| 171 | cell proliferation in forebrain (GO:0021846) | 2.39925968 |
| 172 | dentate gyrus development (GO:0021542) | 2.38895163 |
| 173 | primary amino compound metabolic process (GO:1901160) | 2.38690519 |
| 174 | eye photoreceptor cell development (GO:0042462) | 2.38564870 |
| 175 | microtubule anchoring (GO:0034453) | 2.37956592 |
| 176 | serotonin metabolic process (GO:0042428) | 2.37033973 |
| 177 | adaptation of signaling pathway (GO:0023058) | 2.35742583 |
| 178 | behavioral response to ethanol (GO:0048149) | 2.35105936 |
| 179 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.34152190 |
| 180 | regulation of dopamine secretion (GO:0014059) | 2.33842558 |
| 181 | polyol catabolic process (GO:0046174) | 2.33198161 |
| 182 | retinal cone cell development (GO:0046549) | 2.32622436 |
| 183 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.29218435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94492855 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.45326987 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.20648140 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88857633 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77304316 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70431644 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58798238 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53769891 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37078119 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37025154 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36888849 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29811054 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28530896 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28530896 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.24278085 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17413757 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17083454 |
| 18 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.11993426 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10290950 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.09503158 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09091829 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05182149 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.96264196 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94274056 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94071247 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93117597 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92879476 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92878627 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91116199 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90076158 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89774570 |
| 32 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.85855213 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81494275 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78100549 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75552982 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74707538 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72309445 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72103707 |
| 39 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.71341790 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68286980 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64800405 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.63670266 |
| 43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63307035 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.63079462 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62412844 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57171349 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.56868285 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54582213 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53261977 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52904246 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51820392 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48519037 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48519037 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46959007 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46378979 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43807356 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41371123 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40619860 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39857725 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.37981304 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36239190 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35953210 |
| 63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.35635267 |
| 64 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.34283012 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33930413 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31386091 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.31277458 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28460264 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28414943 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.26520708 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25795419 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25525057 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24008056 |
| 74 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.23908092 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23478737 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23096252 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21062986 |
| 78 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20599790 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20599790 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19398897 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17586896 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17440966 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16529132 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15781571 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15465085 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14362097 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13899354 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13875669 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13832439 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13667959 |
| 91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.13305921 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13189005 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12661470 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12176044 |
| 95 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12075544 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11393167 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11131472 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11004483 |
| 99 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10141527 |
| 100 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09731202 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08743024 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08490071 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07589588 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07418739 |
| 105 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07352639 |
| 106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06533773 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06214799 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06031330 |
| 109 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05635515 |
| 110 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05329223 |
| 111 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05282777 |
| 112 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05044296 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04981493 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04755072 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04479885 |
| 116 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04120248 |
| 117 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04070828 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03491214 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03333051 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02728961 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02034826 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01614000 |
| 123 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00072698 |
| 124 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99947237 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99942137 |
| 126 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99303705 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99303705 |
| 128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99064951 |
| 129 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98133991 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96859464 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96665294 |
| 132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96606353 |
| 133 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93551671 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93388639 |
| 135 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.92783706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.59591462 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.82391729 |
| 3 | MP0004270_analgesia | 3.52269400 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.34763202 |
| 5 | MP0008877_abnormal_DNA_methylation | 3.21372906 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.10241063 |
| 7 | MP0002735_abnormal_chemical_nociception | 2.89246889 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.81014877 |
| 9 | MP0002064_seizures | 2.70056359 |
| 10 | MP0009745_abnormal_behavioral_response | 2.69804068 |
| 11 | MP0002272_abnormal_nervous_system | 2.67226498 |
| 12 | MP0009046_muscle_twitch | 2.65501769 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.60597393 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.59303143 |
| 15 | MP0001529_abnormal_vocalization | 2.51844242 |
| 16 | MP0001486_abnormal_startle_reflex | 2.49328328 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.48545158 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.41326828 |
| 19 | MP0002736_abnormal_nociception_after | 2.39014844 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.35480484 |
| 21 | MP0001905_abnormal_dopamine_level | 2.35138649 |
| 22 | MP0000778_abnormal_nervous_system | 2.34492543 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.24266239 |
| 24 | MP0003122_maternal_imprinting | 2.16189137 |
| 25 | MP0001984_abnormal_olfaction | 2.07430799 |
| 26 | MP0001970_abnormal_pain_threshold | 2.06665577 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 2.06121428 |
| 28 | MP0001188_hyperpigmentation | 2.05910557 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.05873891 |
| 30 | MP0003195_calcinosis | 2.03172143 |
| 31 | MP0005171_absent_coat_pigmentation | 1.97118727 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.92245619 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.90640185 |
| 34 | MP0002184_abnormal_innervation | 1.80582332 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.67808641 |
| 36 | MP0000920_abnormal_myelination | 1.64094801 |
| 37 | MP0004142_abnormal_muscle_tone | 1.62216821 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.59645440 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.55452572 |
| 40 | MP0004742_abnormal_vestibular_system | 1.54383683 |
| 41 | MP0008872_abnormal_physiological_respon | 1.51057168 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.50995168 |
| 43 | MP0002822_catalepsy | 1.49013453 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.48651115 |
| 45 | MP0004924_abnormal_behavior | 1.46957597 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.46957597 |
| 47 | MP0004133_heterotaxia | 1.45208766 |
| 48 | MP0008569_lethality_at_weaning | 1.43230217 |
| 49 | MP0000955_abnormal_spinal_cord | 1.42939740 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.39834843 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.38459997 |
| 52 | MP0003787_abnormal_imprinting | 1.35534036 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.33741124 |
| 54 | MP0002928_abnormal_bile_duct | 1.33504719 |
| 55 | MP0003879_abnormal_hair_cell | 1.32251669 |
| 56 | MP0008995_early_reproductive_senescence | 1.30848863 |
| 57 | MP0005409_darkened_coat_color | 1.29531747 |
| 58 | MP0004147_increased_porphyrin_level | 1.27683998 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.26598217 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.25972093 |
| 61 | MP0004134_abnormal_chest_morphology | 1.24498665 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.23300771 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.21843993 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.21787837 |
| 65 | MP0003950_abnormal_plasma_membrane | 1.20752794 |
| 66 | MP0003329_amyloid_beta_deposits | 1.19555171 |
| 67 | MP0005389_reproductive_system_phenotype | 1.19264382 |
| 68 | MP0002752_abnormal_somatic_nervous | 1.16546166 |
| 69 | MP0002160_abnormal_reproductive_system | 1.14834552 |
| 70 | MP0004885_abnormal_endolymph | 1.14237933 |
| 71 | MP0002229_neurodegeneration | 1.14012273 |
| 72 | MP0004858_abnormal_nervous_system | 1.13419236 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.13242908 |
| 74 | MP0003890_abnormal_embryonic-extraembry | 1.12999596 |
| 75 | MP0002163_abnormal_gland_morphology | 1.11057599 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 1.10858625 |
| 77 | MP0008260_abnormal_autophagy | 1.10271560 |
| 78 | MP0003634_abnormal_glial_cell | 1.08948484 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.08102393 |
| 80 | MP0000427_abnormal_hair_cycle | 1.07795907 |
| 81 | MP0003724_increased_susceptibility_to | 1.06960536 |
| 82 | MP0003011_delayed_dark_adaptation | 1.04916099 |
| 83 | MP0002152_abnormal_brain_morphology | 1.03670772 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.03528699 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03259636 |
| 86 | MP0003136_yellow_coat_color | 1.02766335 |
| 87 | MP0002751_abnormal_autonomic_nervous | 1.00634110 |
| 88 | MP0001485_abnormal_pinna_reflex | 1.00222862 |
| 89 | MP0005187_abnormal_penis_morphology | 1.00015209 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.99550534 |
| 91 | MP0000026_abnormal_inner_ear | 0.98497026 |
| 92 | MP0002909_abnormal_adrenal_gland | 0.97320122 |
| 93 | MP0001919_abnormal_reproductive_system | 0.96007483 |
| 94 | MP0002938_white_spotting | 0.95303826 |
| 95 | MP0003646_muscle_fatigue | 0.94654073 |
| 96 | MP0005253_abnormal_eye_physiology | 0.94363450 |
| 97 | MP0002234_abnormal_pharynx_morphology | 0.91215355 |
| 98 | MP0003283_abnormal_digestive_organ | 0.90703579 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.90507676 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.90023274 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.89509679 |
| 102 | MP0003631_nervous_system_phenotype | 0.88792138 |
| 103 | MP0003938_abnormal_ear_development | 0.88610316 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.86745284 |
| 105 | MP0003121_genomic_imprinting | 0.85832902 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.84278756 |
| 107 | MP0004043_abnormal_pH_regulation | 0.82175545 |
| 108 | MP0002102_abnormal_ear_morphology | 0.82097981 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.81965420 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.81953936 |
| 111 | MP0003119_abnormal_digestive_system | 0.81773873 |
| 112 | MP0003633_abnormal_nervous_system | 0.81736513 |
| 113 | MP0001324_abnormal_eye_pigmentation | 0.81419205 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.80184252 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.80170108 |
| 116 | MP0005499_abnormal_olfactory_system | 0.80170108 |
| 117 | MP0003632_abnormal_nervous_system | 0.76476426 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.71998544 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.67793373 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.66796720 |
| 121 | MP0000751_myopathy | 0.66124878 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.65737740 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.65327070 |
| 124 | MP0003861_abnormal_nervous_system | 0.64635729 |
| 125 | MP0004085_abnormal_heartbeat | 0.63798876 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.63610825 |
| 127 | MP0005195_abnormal_posterior_eye | 0.62171420 |
| 128 | MP0001664_abnormal_digestion | 0.61938822 |
| 129 | MP0003690_abnormal_glial_cell | 0.60800768 |
| 130 | MP0005410_abnormal_fertilization | 0.59755722 |
| 131 | MP0001177_atelectasis | 0.59630613 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.58085154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.87617594 |
| 2 | Myokymia (HP:0002411) | 4.67090447 |
| 3 | Atonic seizures (HP:0010819) | 4.46287444 |
| 4 | Pancreatic cysts (HP:0001737) | 4.38338144 |
| 5 | True hermaphroditism (HP:0010459) | 4.15425711 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.08263725 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.98651498 |
| 8 | Febrile seizures (HP:0002373) | 3.90916386 |
| 9 | Abnormality of midbrain morphology (HP:0002418) | 3.89871772 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.89871772 |
| 11 | Nephronophthisis (HP:0000090) | 3.83756324 |
| 12 | Focal seizures (HP:0007359) | 3.82455286 |
| 13 | Abnormal hair whorl (HP:0010721) | 3.66653442 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.46763262 |
| 15 | Limb dystonia (HP:0002451) | 3.39540116 |
| 16 | Abnormality of the renal medulla (HP:0100957) | 3.39235195 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 3.36570992 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.34067721 |
| 19 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.34067721 |
| 20 | Hyperventilation (HP:0002883) | 3.26454492 |
| 21 | Gait imbalance (HP:0002141) | 3.19182529 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.11746829 |
| 23 | Visual hallucinations (HP:0002367) | 3.11650185 |
| 24 | Medial flaring of the eyebrow (HP:0010747) | 3.07189571 |
| 25 | Pheochromocytoma (HP:0002666) | 3.04713141 |
| 26 | Genetic anticipation (HP:0003743) | 3.02491474 |
| 27 | Hypothermia (HP:0002045) | 3.00756480 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.00748760 |
| 29 | Absence seizures (HP:0002121) | 2.98047820 |
| 30 | Renal cortical cysts (HP:0000803) | 2.92814311 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 2.87558988 |
| 32 | Congenital primary aphakia (HP:0007707) | 2.86306284 |
| 33 | Ankle clonus (HP:0011448) | 2.84012239 |
| 34 | Nephrogenic diabetes insipidus (HP:0009806) | 2.82497957 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.79273814 |
| 36 | Retinal dysplasia (HP:0007973) | 2.73140918 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 2.72215217 |
| 38 | Type II lissencephaly (HP:0007260) | 2.71422581 |
| 39 | Dialeptic seizures (HP:0011146) | 2.69995402 |
| 40 | Sensory axonal neuropathy (HP:0003390) | 2.67117720 |
| 41 | Vaginal atresia (HP:0000148) | 2.60265497 |
| 42 | Genital tract atresia (HP:0001827) | 2.59823430 |
| 43 | Cystic liver disease (HP:0006706) | 2.59077010 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.57822006 |
| 45 | Dysmetria (HP:0001310) | 2.56410701 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 2.56218490 |
| 47 | White forelock (HP:0002211) | 2.51543937 |
| 48 | Fair hair (HP:0002286) | 2.50205717 |
| 49 | Termporal pattern (HP:0011008) | 2.48792906 |
| 50 | Insidious onset (HP:0003587) | 2.48792906 |
| 51 | Broad-based gait (HP:0002136) | 2.46248082 |
| 52 | Polyphagia (HP:0002591) | 2.42047515 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.40166227 |
| 54 | Abnormality of glycolysis (HP:0004366) | 2.40166227 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39433426 |
| 56 | Patchy hypopigmentation of hair (HP:0011365) | 2.38868885 |
| 57 | Chronic hepatic failure (HP:0100626) | 2.37766572 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.37338879 |
| 59 | Specific learning disability (HP:0001328) | 2.35849717 |
| 60 | Scanning speech (HP:0002168) | 2.31789087 |
| 61 | Truncal ataxia (HP:0002078) | 2.28777673 |
| 62 | Spastic gait (HP:0002064) | 2.27766441 |
| 63 | Esotropia (HP:0000565) | 2.27347619 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.27258323 |
| 65 | Narrow nasal bridge (HP:0000446) | 2.26823112 |
| 66 | Attenuation of retinal blood vessels (HP:0007843) | 2.24620093 |
| 67 | Protruding tongue (HP:0010808) | 2.23086166 |
| 68 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.22752746 |
| 69 | Progressive inability to walk (HP:0002505) | 2.22548914 |
| 70 | Excessive salivation (HP:0003781) | 2.21586420 |
| 71 | Drooling (HP:0002307) | 2.21586420 |
| 72 | Action tremor (HP:0002345) | 2.20462806 |
| 73 | Furrowed tongue (HP:0000221) | 2.18346551 |
| 74 | Volvulus (HP:0002580) | 2.16535283 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.16064450 |
| 76 | Pachygyria (HP:0001302) | 2.15036071 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.15027540 |
| 78 | Hyperalaninemia (HP:0003348) | 2.15027540 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15027540 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.14533377 |
| 81 | Inability to walk (HP:0002540) | 2.14073334 |
| 82 | Decreased central vision (HP:0007663) | 2.12210887 |
| 83 | Abnormal drinking behavior (HP:0030082) | 2.11449334 |
| 84 | Polydipsia (HP:0001959) | 2.11449334 |
| 85 | Sclerocornea (HP:0000647) | 2.10994607 |
| 86 | Poor coordination (HP:0002370) | 2.10528040 |
| 87 | Thickened helices (HP:0000391) | 2.09418027 |
| 88 | Abnormality of salivation (HP:0100755) | 2.07578108 |
| 89 | Anencephaly (HP:0002323) | 2.07461631 |
| 90 | Mitochondrial inheritance (HP:0001427) | 2.07227518 |
| 91 | Male pseudohermaphroditism (HP:0000037) | 2.05289179 |
| 92 | Congenital sensorineural hearing impairment (HP:0008527) | 2.04223838 |
| 93 | Amblyopia (HP:0000646) | 2.03572119 |
| 94 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.03417707 |
| 95 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02770490 |
| 96 | Abnormal eating behavior (HP:0100738) | 2.01223792 |
| 97 | Tubular atrophy (HP:0000092) | 2.01144201 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 2.00897904 |
| 99 | Intestinal atresia (HP:0011100) | 2.00810376 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 2.00384090 |
| 101 | Asplenia (HP:0001746) | 1.98754494 |
| 102 | Pendular nystagmus (HP:0012043) | 1.97690250 |
| 103 | Absent speech (HP:0001344) | 1.97481429 |
| 104 | Stomach cancer (HP:0012126) | 1.96963275 |
| 105 | Poor suck (HP:0002033) | 1.96506600 |
| 106 | Increased corneal curvature (HP:0100692) | 1.96075220 |
| 107 | Keratoconus (HP:0000563) | 1.96075220 |
| 108 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.95073461 |
| 109 | Optic disc pallor (HP:0000543) | 1.95035326 |
| 110 | Anxiety (HP:0000739) | 1.94252732 |
| 111 | Postaxial foot polydactyly (HP:0001830) | 1.93741164 |
| 112 | Leukodystrophy (HP:0002415) | 1.92923899 |
| 113 | Blue irides (HP:0000635) | 1.92071725 |
| 114 | Optic nerve hypoplasia (HP:0000609) | 1.90833487 |
| 115 | Poor speech (HP:0002465) | 1.90436657 |
| 116 | Postaxial hand polydactyly (HP:0001162) | 1.89749417 |
| 117 | Hemiparesis (HP:0001269) | 1.89618481 |
| 118 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.88995516 |
| 119 | Congenital hepatic fibrosis (HP:0002612) | 1.88660054 |
| 120 | Heterochromia iridis (HP:0001100) | 1.88610991 |
| 121 | Hepatocellular necrosis (HP:0001404) | 1.87414017 |
| 122 | Chorioretinal atrophy (HP:0000533) | 1.87037183 |
| 123 | Peripheral hypomyelination (HP:0007182) | 1.86919003 |
| 124 | Akinesia (HP:0002304) | 1.86066640 |
| 125 | Broad foot (HP:0001769) | 1.85869381 |
| 126 | Widely spaced teeth (HP:0000687) | 1.85439895 |
| 127 | Lissencephaly (HP:0001339) | 1.85001863 |
| 128 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.84755993 |
| 129 | Decreased circulating renin level (HP:0003351) | 1.83380107 |
| 130 | Acute encephalopathy (HP:0006846) | 1.83272061 |
| 131 | Methylmalonic aciduria (HP:0012120) | 1.83184062 |
| 132 | Cerebral hypomyelination (HP:0006808) | 1.82895541 |
| 133 | Failure to thrive in infancy (HP:0001531) | 1.82830812 |
| 134 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82120524 |
| 135 | Hypoplasia of the brainstem (HP:0002365) | 1.81712745 |
| 136 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.81712745 |
| 137 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81664146 |
| 138 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81637639 |
| 139 | Narrow forehead (HP:0000341) | 1.81303058 |
| 140 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79682609 |
| 141 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79682609 |
| 142 | Xerostomia (HP:0000217) | 1.79561482 |
| 143 | Psychosis (HP:0000709) | 1.77838193 |
| 144 | Fetal akinesia sequence (HP:0001989) | 1.76950403 |
| 145 | Aplasia involving bones of the extremities (HP:0009825) | 1.75711818 |
| 146 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75711818 |
| 147 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75711818 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75414995 |
| 149 | Parakeratosis (HP:0001036) | 1.75305473 |
| 150 | Hypochromic microcytic anemia (HP:0004840) | 1.74802770 |
| 151 | Oligodactyly (hands) (HP:0001180) | 1.74797104 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.74787604 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.74787604 |
| 154 | Epileptiform EEG discharges (HP:0011182) | 1.74572126 |
| 155 | Abnormality of the labia minora (HP:0012880) | 1.72945449 |
| 156 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72295701 |
| 157 | Short foot (HP:0001773) | 1.72290505 |
| 158 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.72259586 |
| 159 | Dysdiadochokinesis (HP:0002075) | 1.72231447 |
| 160 | Agitation (HP:0000713) | 1.70825712 |
| 161 | Tented upper lip vermilion (HP:0010804) | 1.70768372 |
| 162 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.70042880 |
| 163 | Urinary urgency (HP:0000012) | 1.68308431 |
| 164 | Exotropia (HP:0000577) | 1.66688570 |
| 165 | Polyuria (HP:0000103) | 1.66404504 |
| 166 | Autoamputation (HP:0001218) | 1.66031546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.52476923 |
| 2 | CASK | 4.40129622 |
| 3 | MAP4K2 | 3.50598666 |
| 4 | MAP3K12 | 3.43490986 |
| 5 | MAP2K7 | 3.23756733 |
| 6 | TNIK | 3.05331861 |
| 7 | MARK1 | 2.69454784 |
| 8 | NTRK3 | 2.66734402 |
| 9 | MAP3K4 | 2.65862331 |
| 10 | CDK19 | 2.37655488 |
| 11 | SIK3 | 2.28208712 |
| 12 | PRPF4B | 2.26294493 |
| 13 | TAOK3 | 2.24252416 |
| 14 | EPHA4 | 2.10183583 |
| 15 | NEK1 | 2.07333361 |
| 16 | OXSR1 | 2.02514998 |
| 17 | NUAK1 | 1.91508025 |
| 18 | PINK1 | 1.88963644 |
| 19 | STK39 | 1.87251161 |
| 20 | MAPK13 | 1.84355076 |
| 21 | GRK1 | 1.82471000 |
| 22 | MINK1 | 1.81168801 |
| 23 | AKT3 | 1.78763143 |
| 24 | TRIM28 | 1.76728290 |
| 25 | BCR | 1.71158632 |
| 26 | GRK5 | 1.69261970 |
| 27 | MAP3K9 | 1.67103124 |
| 28 | PLK2 | 1.62245748 |
| 29 | DYRK2 | 1.51848140 |
| 30 | LIMK1 | 1.49425125 |
| 31 | MAP2K4 | 1.47618390 |
| 32 | MAPKAPK5 | 1.45006112 |
| 33 | ACVR1B | 1.43985001 |
| 34 | NTRK2 | 1.42940782 |
| 35 | UHMK1 | 1.40899252 |
| 36 | TXK | 1.38139157 |
| 37 | CSNK1G3 | 1.36796514 |
| 38 | SGK494 | 1.34224356 |
| 39 | SGK223 | 1.34224356 |
| 40 | CSNK1G2 | 1.31121826 |
| 41 | ARAF | 1.28992413 |
| 42 | INSRR | 1.28058141 |
| 43 | PNCK | 1.23146048 |
| 44 | BMPR2 | 1.22040251 |
| 45 | PAK6 | 1.19783118 |
| 46 | CDK5 | 1.16802946 |
| 47 | DAPK1 | 1.13643404 |
| 48 | MUSK | 1.09633658 |
| 49 | CSNK1A1L | 1.07698965 |
| 50 | GRK7 | 1.05333769 |
| 51 | DAPK2 | 1.04585404 |
| 52 | CAMK2B | 1.01813813 |
| 53 | BMPR1B | 1.01543811 |
| 54 | ZAK | 1.01158311 |
| 55 | PRKCG | 0.99897172 |
| 56 | PRKCE | 0.99781956 |
| 57 | CDK18 | 0.98103515 |
| 58 | STK38L | 0.96682100 |
| 59 | YES1 | 0.94906752 |
| 60 | CCNB1 | 0.93538258 |
| 61 | CAMK2A | 0.93457276 |
| 62 | CDK14 | 0.93054003 |
| 63 | FGFR2 | 0.92616467 |
| 64 | TLK1 | 0.91246085 |
| 65 | NTRK1 | 0.88124802 |
| 66 | CDK15 | 0.87366776 |
| 67 | KSR1 | 0.86456687 |
| 68 | RIPK4 | 0.80780843 |
| 69 | CAMKK2 | 0.79732090 |
| 70 | CDK11A | 0.79358118 |
| 71 | CSNK1G1 | 0.79076417 |
| 72 | ADRBK2 | 0.78368560 |
| 73 | CDK8 | 0.77983627 |
| 74 | WNK3 | 0.76596661 |
| 75 | BRSK2 | 0.75472636 |
| 76 | TIE1 | 0.69725526 |
| 77 | NEK2 | 0.69448745 |
| 78 | PKN1 | 0.69242669 |
| 79 | DYRK3 | 0.68791243 |
| 80 | DYRK1A | 0.65308296 |
| 81 | SGK2 | 0.64964756 |
| 82 | MARK2 | 0.63387432 |
| 83 | CAMK2D | 0.63372790 |
| 84 | GRK6 | 0.62690594 |
| 85 | TYRO3 | 0.62389326 |
| 86 | NEK6 | 0.62137078 |
| 87 | TSSK6 | 0.62073832 |
| 88 | TAF1 | 0.59914681 |
| 89 | ERBB2 | 0.58650894 |
| 90 | PAK3 | 0.58646212 |
| 91 | ADRBK1 | 0.58379963 |
| 92 | CAMK4 | 0.57167025 |
| 93 | TEC | 0.56265832 |
| 94 | TNK2 | 0.55518778 |
| 95 | ERBB3 | 0.55186527 |
| 96 | CDK3 | 0.54791041 |
| 97 | MKNK1 | 0.54107989 |
| 98 | SYK | 0.53904553 |
| 99 | ROCK2 | 0.53440191 |
| 100 | PHKG2 | 0.53195615 |
| 101 | PHKG1 | 0.53195615 |
| 102 | FGR | 0.53169410 |
| 103 | CAMK1 | 0.52795442 |
| 104 | TAOK2 | 0.52086636 |
| 105 | MKNK2 | 0.51906407 |
| 106 | PTK2B | 0.50017408 |
| 107 | CSNK1D | 0.49730420 |
| 108 | BRAF | 0.48621091 |
| 109 | IRAK2 | 0.48308228 |
| 110 | FES | 0.48298612 |
| 111 | IKBKE | 0.47904153 |
| 112 | SIK2 | 0.47754994 |
| 113 | VRK1 | 0.47577184 |
| 114 | EPHB1 | 0.47315466 |
| 115 | PLK3 | 0.46669752 |
| 116 | MST4 | 0.46163026 |
| 117 | MAP3K6 | 0.44793942 |
| 118 | CSNK1A1 | 0.44764783 |
| 119 | CAMK2G | 0.44372942 |
| 120 | STK16 | 0.43276617 |
| 121 | WNK4 | 0.42774446 |
| 122 | EPHA3 | 0.42469212 |
| 123 | STK11 | 0.40120970 |
| 124 | ITK | 0.39325300 |
| 125 | WNK1 | 0.39316159 |
| 126 | FYN | 0.39247361 |
| 127 | STK3 | 0.38567362 |
| 128 | PRKCZ | 0.38548014 |
| 129 | MATK | 0.38190137 |
| 130 | MYLK | 0.36532241 |
| 131 | IRAK1 | 0.36039669 |
| 132 | PIK3CA | 0.35075218 |
| 133 | MAP2K6 | 0.34950502 |
| 134 | EPHB2 | 0.34792689 |
| 135 | PRKACA | 0.34684860 |
| 136 | MAPK7 | 0.34602224 |
| 137 | PRKG1 | 0.33662190 |
| 138 | PRKCQ | 0.33604876 |
| 139 | IGF1R | 0.32944638 |
| 140 | RPS6KA5 | 0.32490244 |
| 141 | EGFR | 0.32125086 |
| 142 | PRKACB | 0.32026097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.43285124 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.23687152 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63129649 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.56528639 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45987809 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45135483 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.43617503 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.33705842 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.31957445 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.31124932 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.29619807 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28269746 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27393291 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.24795571 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.23537141 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22527219 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.22130839 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09009052 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.97606481 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.91894301 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.90540699 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.87160689 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84205855 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79559028 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.79093655 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.75124392 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69467097 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68388601 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65051495 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64210951 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64035385 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.61054113 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53582985 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.45473036 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.42311151 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38354036 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35665757 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34710242 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34402228 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.33960235 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.29695210 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26753594 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22220260 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21150117 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17884502 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.14290917 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13591675 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11367555 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10861636 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10109707 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09634408 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08584986 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.07347557 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04692684 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04674271 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.03988814 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03958736 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03191616 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01439697 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00577968 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96930392 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96513946 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94343116 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93448941 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92424982 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.91234975 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89956998 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.88870583 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88246053 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87486342 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.86106699 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84351516 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84169900 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83113419 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.80418815 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80115045 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80034929 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.78959314 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74572239 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.73334648 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72123681 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72072149 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71874029 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.70576315 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.69477380 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69412521 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69405523 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68774771 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68397560 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64266486 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62312084 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62229145 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61867782 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61614732 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61456208 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61270538 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60870819 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.59429093 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58926687 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57745131 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57652304 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57223716 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57126766 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56133178 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55823112 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55437386 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54422702 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54128046 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53752351 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51997490 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51547195 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.50321091 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48260266 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.48026368 |
| 115 | Proteasome_Homo sapiens_hsa03050 | 0.47218285 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47133698 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46572425 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46351814 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44828084 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44383104 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43854489 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42576590 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.42287376 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41597592 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39026098 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38481461 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37293583 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36751527 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.36698022 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36634726 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36217981 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.35483255 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34548151 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33113113 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31734051 |
| 136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31534628 |
| 137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30937904 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29090312 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28059348 |
| 140 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25986494 |
| 141 | Basal transcription factors_Homo sapiens_hsa03022 | 0.25964400 |
| 142 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25751059 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25383603 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.24370241 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.21080031 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21075322 |

